Ablation of Tumor Using EUS

  • Hyoung-Chul Oh
  • Woo Hyun Paik
  • Tae Jun Song
  • Dong Wan SeoEmail author


EUS started as an imaging tool for deeply seated organ and pathology. After introduction of EUS-guided fine needle aspiration (FNA), EUS became an important tool for histologic diagnosis of pancreatic, peripancreatic, mediastinal, retroperitoneal, and gastrointestinal tract lesions. Therapeutic and interventional EUS started by modification of EUS-FNA technology and EUS-guided pseudocyst drainage is increasingly used for the management of pancreatic pseudocyst. EUS-guided ablation of pancreatic solid mass is also tried by ethanol injection. Radiofrequency ablation has long been used to ablate hepatic tumors via percutaneous route. Recently, EUS-guided RFA probe was introduced and is cautiously applied for the ablation of pancreatic solid tumors. EUS-guided pancreatic cyst ablation has been investigated in a variety of clinical studies. EUS-guided pancreatic cyst ablation is safe and feasible and shows potential to become an alternative to surgery. In this chapter, EUS-guided ablation of pancreatic cysts, EUS-guided injection therapy of benign solid mass, and EUS-guided RFA will be discussed.


Endoscopic ultrasonography Pancreatic cyst Ablation 


  1. 1.
    Brugge WR, Lauwers GY, Sahani D, Fernandez-del Castillo C, Warshaw AL. Cystic neoplasms of the pancreas. N Engl J Med. 2004;351(12):1218–26.CrossRefPubMedGoogle Scholar
  2. 2.
    Oh HC, Kim MH, Hwang CY, Lee TY, Lee SS, Seo DW, et al. Cystic lesions of the pancreas: challenging issues in clinical practice. Am J Gastroenterol. 2008;103(1):229–39; quiz 8, 40. AJG1558 [pii].CrossRefPubMedGoogle Scholar
  3. 3.
    Oh HC, Seo DW, Song TJ, Moon SH, Park DH, Soo Lee S, et al. Endoscopic ultrasonography-guided ethanol lavage with paclitaxel injection treats patients with pancreatic cysts. Gastroenterology. 2011;140(1):172–9. S0016-5085(10)01458-7 [pii].CrossRefPubMedGoogle Scholar
  4. 4.
    Allen PJ, D’Angelica M, Gonen M, Jaques DP, Coit DG, Jarnagin WR, et al. A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. Ann Surg. 2006;244(4):572–82. 00000658-200610000-00012 [pii].CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Gaujoux S, Brennan MF, Gonen M, D’Angelica MI, DeMatteo R, Fong Y, et al. Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15-year time period. J Am Coll Surg. 2011;212(4):590–600.; discussion 600–3. Scholar
  6. 6.
    Aslanian H, Salem RR, Marginean C, Robert M, Lee JH, Topazian M. EUS-guided ethanol injection of normal porcine pancreas: a pilot study. Gastrointest Endosc. 2005;62(5):723–7. S0016-5107(05)02537-X [pii].CrossRefPubMedGoogle Scholar
  7. 7.
    Matthes K, Mino-Kenudson M, Sahani DV, Holalkere N, Brugge WR. Concentration-dependent ablation of pancreatic tissue by EUS-guided ethanol injection. Gastrointest Endosc. 2007;65(2):272–7. S0016-5107(06)01919-5 [pii].CrossRefPubMedGoogle Scholar
  8. 8.
    Matthes K, Mino-Kenudson M, Sahani DV, Holalkere N, Fowers KD, Rathi R, et al. EUS-guided injection of paclitaxel (OncoGel) provides therapeutic drug concentrations in the porcine pancreas (with video). Gastrointest Endosc. 2007;65(3):448–53.CrossRefPubMedGoogle Scholar
  9. 9.
    Gan SI, Thompson CC, Lauwers GY, Bounds BC, Brugge WR. Ethanol lavage of pancreatic cystic lesions: initial pilot study. Gastrointest Endosc. 2005;61(6):746–52.CrossRefPubMedGoogle Scholar
  10. 10.
    DeWitt J, DiMaio CJ, Brugge WR. Long-term follow-up of pancreatic cysts that resolve radiologically after EUS-guided ethanol ablation. Gastrointest Endosc. 2010;72(4):862–6. S0016-5107(10)00251-8 [pii].CrossRefPubMedGoogle Scholar
  11. 11.
    Oh HC, Brugge WR. EUS-guided pancreatic cyst ablation: a critical review (with video). Gastrointest Endosc. 2013;77(4):526–33. Scholar
  12. 12.
    Gomez V, Takahashi N, Levy MJ, McGee KP, Jones A, Huang Y, et al. EUS-guided ethanol lavage does not reliably ablate pancreatic cystic neoplasms (with video). Gastrointest Endosc. 2016;83(5):914–20. Scholar
  13. 13.
    Bean WJ, Rodan BA. Hepatic cysts: treatment with alcohol. AJR Am J Roentgenol. 1985;144(2):237–41. Scholar
  14. 14.
    Gelczer RK, Charboneau JW, Hussain S, Brown DL. Complications of percutaneous ethanol ablation. J Ultrasound Med. 1998;17(8):531–3.CrossRefPubMedGoogle Scholar
  15. 15.
    Rowinsky EK, Donehower RC. Paclitaxel (taxol). N Engl J Med. 1995;332(15):1004–14. CrossRefPubMedGoogle Scholar
  16. 16.
    DeWitt J, McGreevy K, Schmidt CM, Brugge WR. EUS-guided ethanol versus saline solution lavage for pancreatic cysts: a randomized, double-blind study. Gastrointest Endosc. 2009;70(4):710–23. S0016-5107(09)01716-7 [pii].CrossRefPubMedGoogle Scholar
  17. 17.
    Oh HC, Seo DW, Lee TY, Kim JY, Lee SS, Lee SK, et al. New treatment for cystic tumors of the pancreas: EUS-guided ethanol lavage with paclitaxel injection. Gastrointest Endosc. 2008;67(4):636–42. S0016-5107(07)02811-8 [pii].CrossRefPubMedGoogle Scholar
  18. 18.
    Oh HC, Seo DW, Kim SC, Yu E, Kim K, Moon SH, et al. Septated cystic tumors of the pancreas: is it possible to treat them by endoscopic ultrasonography-guided intervention? Scand J Gastroenterol. 2009;44(2):242–7. 904749592 [pii].CrossRefPubMedGoogle Scholar
  19. 19.
    DiMaio CJ, DeWitt JM, Brugge WR. Ablation of pancreatic cystic lesions: the use of multiple endoscopic ultrasound-guided ethanol lavage sessions. Pancreas. 2011;40(5):664–8. Scholar
  20. 20.
    Oh HC, Seo DW, Song TJ. Resolution of a septated pancreatic cyst by booster endoscopic ultrasonography-guided ablation. J Dig Dis. 2011;12(6):497–9. Scholar
  21. 21.
    Oh HC, Seo DW, Kim SC. Portal vein thrombosis after EUS-guided pancreatic cyst ablation. Dig Dis Sci. 2012;57(7):1965–7. Scholar
  22. 22.
    DeWitt JM, Al-Haddad M, Sherman S, LeBlanc J, Schmidt CM, Sandrasegaran K, et al. Alterations in cyst fluid genetics following endoscopic ultrasound-guided pancreatic cyst ablation with ethanol and paclitaxel. Endoscopy. 2014;46(6):457–64. Scholar
  23. 23.
    Tseng JF, Warshaw AL, Sahani DV, Lauwers GY, Rattner DW, Fernandez-del CC. Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment. Ann Surg. 2005;242(3):413–9; discussion 9–21. 00000658-200509000-00012 [pii].PubMedPubMedCentralGoogle Scholar
  24. 24.
    Khashab MA, Shin EJ, Amateau S, Canto MI, Hruban RH, Fishman EK, et al. Tumor size and location correlate with behavior of pancreatic serous cystic neoplasms. Am J Gastroenterol. 2011;106(8):1521–6. Scholar
  25. 25.
    Xu XX, Du Y, Yang HF, Zhang Q, Li Y, Zee CS. CT-guided sclerotherapy with ethanol concentration monitoring for treatment of renal cysts. AJR Am J Roentgenol. 2011;196(1):W78–82. Scholar
  26. 26.
    Puli SR, Kalva N, Bechtold ML, et al. Diagnostic accuracy of endoscopic ultrasound in pancreatic neuroendocrine tumors: a systematic review and meta analysis. World J Gastroenterol. 2013;19:3678–84.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Metz DC, Jensen RT. Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology. 2008;135:1469–92.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Kitano M, Sakamoto H, Kudo M. Endoscopic ultrasound: contrast enhancement. Gastrointest Endosc Clin N Am. 2012;22:349–58, xi.CrossRefPubMedGoogle Scholar
  29. 29.
    Levy MJ, Thompson GB, Topazian MD, et al. US-guided ethanol ablation of insulinomas: a new treatment option. Gastrointest Endosc. 2012;75:200–6.CrossRefPubMedGoogle Scholar
  30. 30.
    Park do H, Choi JH, Oh D, et al. Endoscopic ultrasonography-guided ethanol ablation for small pancreatic neuroendocrine tumors: results of a pilot study. Clin Endosc. 2015;48:158–64.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Paik WH, Seo DW, Dhir V, Wang HP. Safety and efficacy of EUS-guided ethanol ablation for treating small solid pancreatic neoplasm. Medicine (Baltimore). 2016;95:e2538.Google Scholar
  32. 32.
    Deprez PH, Claessens A, Borbath I, et al. Successful endoscopic ultrasound-guided ethanol ablation of a sporadic insulinoma. Acta Gastroenterol Belg. 2008;71:333–7.PubMedGoogle Scholar
  33. 33.
    Kim MK. Endoscopic ultrasound in gastroenteropancreatic neuroendocrine tumors. Gut Liver. 2012;6:405–10.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Song TJ, Seo DW, Lakhtakia S, et al. Initial experience of EUS-guided radiofrequency ablation of unresectable pancreatic cancer. Gastrointest Endosc. 2016;83(2):440–3.CrossRefPubMedGoogle Scholar
  35. 35.
    Goldberg SN, Mallery S, Gazelle GS, et al. EUS-guided radiofrequency ablation in the pancreas: results in a porcine model. Gastrointest Endosc. 1999;50:392–401.CrossRefPubMedGoogle Scholar
  36. 36.
    Carrara S, Arcidiacono PG, Albarello L, et al. Endoscopic ultrasound-guided application of a new hybrid cryotherm probe in porcine pancreas: a preliminary study. Endoscopy. 2008;40:321–6.CrossRefPubMedGoogle Scholar
  37. 37.
    Varadarajulu S, Jhala NC, Drelichman ER. EUS-guided radiofrequency ablation with a prototype electrode array system in an animal model (with video). Gastrointest Endosc. 2009;70:372–6.CrossRefPubMedGoogle Scholar
  38. 38.
    Gaidhane M, Smith I, Ellen K, et al. Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) of the pancreas in a porcine model. Gastroenterol Res Pract. 2012;2012:431451.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Sethi A, Ellrichmann M, Dhar S, et al. Endoscopic ultrasound-guided lymph node ablation with a novel radiofrequency ablation probe: feasibility study in an acute porcine model. Endoscopy. 2014;46:411–5.CrossRefPubMedGoogle Scholar
  40. 40.
    Pai M, Habib N, Senturk H, et al. Endoscopic ultrasound guided radiofrequency ablation, for pancreatic cystic neoplasms and neuroendocrine tumors. World J Gastrointest Surg. 2015;7:52–9.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Frigerio I, Girelli R, Giardino A, et al. Short term chemotherapy followed by radiofrequency ablation in stage III pancreatic cancer: results from a single center. J Hepatobiliary Pancreat Sci. 2013;20:574–7.CrossRefPubMedGoogle Scholar
  42. 42.
    Cantore M, Girelli R, Mambrini A, et al. Combined modality treatment for patients with locally advanced pancreatic adenocarcinoma. Br J Surg. 2012;99(8):1083.CrossRefPubMedGoogle Scholar
  43. 43.
    Haen SP, Pereira PL, Salih HR, et al. More than just tumor destruction: immunomodulation by thermal ablation of cancer. Clin Dev Immunol. 2011;2011:160250.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Waitz R, Solomon SB. Can local radiofrequency ablation of tumors generate systemic immunity against metastatic disease? Radiology. 2009;251:1–2.CrossRefPubMedGoogle Scholar
  45. 45.
    Wu Y, Tang Z, Fang H, et al. High operative risk of cool-tip radiofrequency ablation for unresectable pancreatic head cancer. J Surg Oncol. 2006;94:392–5.CrossRefPubMedGoogle Scholar
  46. 46.
    Elias D, Baton O, Sideris L, et al. Necrotizing pancreatitis after radiofrequency destruction of pancreatic tumours. Eur J Surg Oncol. 2004;30:85–7.CrossRefPubMedGoogle Scholar
  47. 47.
    Yoon WJ, Brugge WR. Endoscopic ultrasonography-guided tumor ablation. Gastrointest Endosc Clin N Am. 2012;22:359–69, xi.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Japan KK, part of Springer Nature 2019

Authors and Affiliations

  • Hyoung-Chul Oh
    • 1
  • Woo Hyun Paik
    • 2
  • Tae Jun Song
    • 3
  • Dong Wan Seo
    • 3
    Email author
  1. 1.Division of GastroenterologyChung-Ang University College of MedicineSeoulKorea
  2. 2.Department of Internal MedicineSeoul National University HospitalSeoulKorea
  3. 3.Department of Internal MedicineUniversity of Ulsan College of Medicine, Asan Medical CenterSeoulKorea

Personalised recommendations